MUNDIPHARMA MEDICAL COMPANY LIMITED
Get an alert when MUNDIPHARMA MEDICAL COMPANY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£100M
+33.5% vs 2023
Net assets
£602M
+935.1% vs 2023
Employees
114
-7.3% vs 2023
Profit before tax
£74M
+41.6% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £337,928,000 | £287,148,000 | -15% | |
| Operating profit | £49,835,000 | £71,255,000 | +43% | |
| Profit before tax | £51,914,000 | £73,521,000 | +41.6% | |
| Net profit | £38,721,000 | £54,417,000 | +40.5% | |
| Cash | £74,694,000 | £99,716,000 | +33.5% | |
| Total assets less current liabilities | £98,133,000 | £641,707,000 | +553.9% | |
| Net assets | £58,133,000 | £601,707,000 | +935.1% | |
| Equity | £58,133,000 | £601,707,000 | +935.1% | |
| Average employees | 123 | 114 | -7.3% | |
| Wages | £12,161,000 | £13,521,000 | +11.2% | |
| Directors' remuneration | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 14.7% | 24.8% | |
| Net margin | 11.5% | 19.0% | |
| Return on capital employed | 50.8% | 11.1% | |
| Gearing (liabilities / total assets) | 82.2% | 28.9% | |
| Current ratio | 1.17x | 2.87x | |
| Interest cover | — | 28.50x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Accordingly, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for a period to 31st October 2026 and, thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- MUNDIPHARMA MEDICAL COMPANY LIMITED · parent
- Mundipharma Biologics SL 100%
- Mundipharma International Services S.a.r.l. 100%
- Mundipharma International Services GmbH 100%
- Mundipharma EDO GmbH 100%
- Mundipharma International Services Limited 100%
- MN Consulting LLC 100%
- Mundipharma Ophthalmology Products Limited 100%
Significant events
- “On December 31, 2024, Mundipharma Medical Company (MMCO), the parent entity, transferred its business assets to the Company. This transaction was to transfer the majority of MMCO's business and associated rights, assets and liabilities to its UK subsidiary.”
- “The Company has a £26,160,000 receivable due from a former related party, now subsidiary, Mundipharma Ophthalmology Products Limited ('MOPL') in connection with Grant of Rights Agreements.”
- “Also in May 2025, the allotment of share issue has been approved in connection with a contribution deed as part of the transaction for acquisition of assets from the parent entity Mundipharma Medical Company (MMCO). There were 1 of each class A ordinary shares and class B ordinary shares issued with a nominal value of £1,000.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2015-08-25 | Jun 1961 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAKER, Stuart David | Director | 2014-10-21 | 2019-12-31 |
| KUDLEK, Birgit, Dr | Director | 2020-01-01 | 2020-10-31 |
| MARTINEZ, Alberto | Director | 2016-10-11 | 2019-10-01 |
| MATTESSICH, Antony Charles | Director | 2015-08-25 | 2017-07-31 |
| SHIELS, Sara Elizabeth | Director | 2015-08-25 | 2018-01-07 |
| SILVER, David Alan | Director | 2015-08-25 | 2019-05-03 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Jeffrey Robins | Individual | Significant influence (as trust) | 2018-11-20 | Active |
| Mrs Alexa Mairi Saunders | Individual | Significant influence (as trust) | 2018-03-05 | Active |
| Mr Peter Minton Ward | Individual | Shares 25–50% (as trust) | 2016-04-06 | Ceased 2018-06-03 |
| Mr Christopher Benbow Mitchell | Individual | Shares 25–50% (as trust) | 2016-04-06 | Ceased 2018-04-12 |
| Mr Leslie John Schreyer | Individual | Shares 25–50% (as trust) | 2016-04-06 | Active |
| Mrs Hermance Bernadette Monique Schaepman | Individual | Shares 25–50% (as trust) | 2016-04-06 | Active |
Filing timeline
Last 20 of 75 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-05-28 RESOLUTIONS Resolution
- 2025-05-28 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-11-04 | AA | accounts | Accounts with accounts type full | |
| 2025-06-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-23 | SH01 | capital | Capital allotment shares | |
| 2025-05-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2025-02-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-08-29 | AA | accounts | Accounts with accounts type full | |
| 2024-06-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2023-10-02 | AA | accounts | Accounts with accounts type group | |
| 2023-06-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-22 | AA | accounts | Accounts with accounts type group | |
| 2022-07-04 | CH01 | officers | Change person director company with change date | |
| 2022-06-22 | AD02 | address | Change sail address company with old address new address | |
| 2022-06-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-05-06 | AA | accounts | Accounts with accounts type group |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.